Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis

Table 3

Colonic mucosal mRNA expression of PPAR𝛾, NF-κB, and TNF-𝛼 (mean ± SD).

Time	Control group			Model group			Rosiglitazone-treated group
	PPARγ	NF-κB	TNF-α	PPARγ	NF-κB	TNF-α	PPARγ	NF-κB	TNF-α
7th d	1.46±0.05	0.05±0.01	0.03±0.01	0.61±0.02 *	0.89±0.10 *	1.08±0.1195 *	0.84±0.02^Δ	0.75±0.08^Δ	0.83±0.11^Δ
14th d	1.46±0.05	0.04±0.00	0.03±0.01	0.71±0.04 *	0.79±0.05 *	0.88±0.04 *	1.05±0.04^Δ	0.53±0.05^Δ	0.72±0.03^Δ
21st d	1.45±0.04	0.04±0.00	0.03±0.00	0.92±0.04 *	0.60±0.05 *	0.73±0.04 *	1.18±0.05^Δ	0.32±0.03^Δ	0.52±0.03^Δ
35th d	1.47±0.06	0.04±0.01	0.03±0.02	0.99±0.05 *	0.54±0.03 *	0.52±0.05 *	1.26±0.06^Δ	0.22±0.03^Δ	0.22±0.03^Δ

Note: *𝑃<0.05 versus control group, ^Δ𝑃<0.05 versus model group.